Product Information
IPRATROPIUM 0.03% SPRAY is a generic product labeled by Advagen Pharma Ltd., priced at $0.3678 per ML under NDC 72888014938. Its NADAC has been published 69 times since Jun 11, 2025.
FDA first approved this application on Jan 14, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
21 ug/1
Manufacturer
Advagen Pharma Ltd.NDC
72888014938
Classification
Generic
Dosage Form
SPRAY, METERED
Route
NASAL
Effective Date
9/23/2026
Active Ingredients
IPRATROPIUM BROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA219222FDA Approved
1/14/2025
TE Code
AB
On Market Since
1/14/2025
Pharmacological Classes
Price Statistics
The NADAC for IPRATROPIUM 0.03% SPRAY has been published 69 times since Jun 11, 2025, and over the history we have for it it has declined 35.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3678 per ML |
|---|---|
| All-time high | $0.6185 (Sep 10, 2025) |
| All-time low | $0.3488 (Jul 22, 2026) |
| 52-week high | $0.5706 |
| 52-week low | $0.3488 |
| Median price | $0.4340 |
| Average price | $0.4642 |
| Largest weekly change | -8.6% (Nov 19, 2025) |
| Weeks tracked | 69 |
| Tracking since | Jun 11, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Advagen Pharma Ltd. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
IPRATROPIUM BROMIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of IPRATROPIUM 0.03% SPRAY?
The current National Average Drug Acquisition Cost (NADAC) for IPRATROPIUM 0.03% SPRAY, manufactured by Advagen Pharma Ltd., is $0.3678 per ML (NDC 72888014938), effective Sep 30, 2026.
How has the price of IPRATROPIUM 0.03% SPRAY changed over time?
Over the history we have for it, the NADAC for IPRATROPIUM 0.03% SPRAY has declined 35.9%. It has been tracked across 69 weekly CMS publications since Jun 11, 2025.
What are the highest and lowest recorded NADAC prices for IPRATROPIUM 0.03% SPRAY?
Since Jun 11, 2025, the NADAC for IPRATROPIUM 0.03% SPRAY has ranged from a low of $0.3488 (Jul 22, 2026) to a high of $0.6185 (Sep 10, 2025), with a median of $0.4340 per ML.
Are there cheaper alternatives to IPRATROPIUM 0.03% SPRAY?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as IPRATROPIUM 0.03% SPRAY in a comparable dosage form, but none are currently priced below it.
Who manufactures IPRATROPIUM 0.03% SPRAY?
IPRATROPIUM 0.03% SPRAY (NDC 72888014938) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.